Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies

Purpose: To report two new cases and summarize one case of uveal melanoma following treatment of hematologic malignancies with Bruton's tyrosine kinase inhibitors. Observations: A 71-year-old male, with a history of Waldenstrom macroglobulinemia treated with an anti-CD20 antibody and BTKi, was...

Full description

Saved in:
Bibliographic Details
Main Authors: Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Uveal melanoma
Bruton's tyrosine kinase inhibitor
Hematologic malignancy
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993625000982
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items